chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Guttate psoriasis
Clinical narrative: Guttate psoriasis/Her symptoms are still ongoing at the moment. It's horrible. It's itchy, all over her body, red, scaly; This spontaneous case was reported by a patient and describes the occurrence of GUTTATE PSORIASIS (Guttate psoriasis/Her symptoms are still ongoing at the moment. It's horrible. It's itchy, all over her body, red, scaly) in a 49-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 013H22A) for COVID-19 prophylaxis.     Previously administered products included for Drug use for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (1st Pfizer dose) on 18-Mar-2021, PFIZER BIONTECH COVID-19 VACCINE (2nd Pfizer dose) on 08-Apr-2021 and PFIZER BIONTECH COVID-19 VACCINE (Pfizer booster dose) on 02-Dec-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 13-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 08-Jan-2023, the patient experienced GUTTATE PSORIASIS (Guttate psoriasis/Her symptoms are still ongoing at the moment. It's horrible. It's itchy, all over her body, red, scaly). At the time of the report, GUTTATE PSORIASIS (Guttate psoriasis/Her symptoms are still ongoing at the moment. It's horrible. It's itchy, all over her body, red, scaly) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant Medication use information was not provided by reporter.  The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  Patient got the Moderna COVID bivalent booster on 13 December 2022. It was the first time she ever had a Moderna shot. On 8 January 2023, patient had guttate psoriasis. the symptoms were still ongoing at the moment. It was horrible and itchy, all over the body, red and scaly. The only parts of body that it was not on her face, both her hands, and both the feet.   It was really bad on her back and hips. It was on her ankles. It was really bad on the back of the legs. The patient dermatologist was not sure if it was due to the Moderna booster bivalent or the Strep A infection. She repeated that it was bad. Her doctor told her it would take 3 months to go away. She will be having UV light therapy and steroid ointment. The patient reported that she never had any reactions from her previous Pfizer shots.  Non drug treatment includes UV light therapy. Also on steroid ointment, drug name not specified. .
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Doses were stored in the fridge since 20Dec2022 and vaccines were administered on 24Jan2023; No adverse event; Pediatric patient was administered with Moderna COVID-19 Vaccine Bivalent doses after 30-day Use By Date (34 days); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Pediatric patient was administered with Moderna COVID-19 Vaccine Bivalent doses after 30-day Use By Date (34 days)), PRODUCT STORAGE ERROR (Doses were stored in the fridge since 20Dec2022 and vaccines were administered on 24Jan2023) and NO ADVERSE EVENT (No adverse event) in an infant patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On 24-Jan-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Pediatric patient was administered with Moderna COVID-19 Vaccine Bivalent doses after 30-day Use By Date (34 days)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Doses were stored in the fridge since 20Dec2022 and vaccines were administered on 24Jan2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Pediatric patient was administered with Moderna COVID-19 Vaccine Bivalent doses after 30-day Use By Date (34 days)), PRODUCT STORAGE ERROR (Doses were stored in the fridge since 20Dec2022 and vaccines were administered on 24Jan2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Pediatric patient was administered with Moderna COVID-19 Vaccine Bivalent doses after 30-day Use By Date (34 days)) and PRODUCT STORAGE ERROR (Doses were stored in the fridge since 20Dec2022 and vaccines were administered on 24Jan2023).    Concomitant product use was not provided by the reporter. This case has information of 2 pediatric patient out of 2 pediatric patient case. Patient received initial booster dose.  It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-706646 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-706646:Master case
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: vial was stored in refrigerator on 28-Dec-2022 and was administered on 31-jan-2023; No adverse event; patient received an expired 2nd primary dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient received an expired 2nd primary dose), PRODUCT STORAGE ERROR (vial was stored in refrigerator on 28-Dec-2022 and was administered on 31-jan-2023) and NO ADVERSE EVENT (No adverse event) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 074B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 31-Jan-2023, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (patient received an expired 2nd primary dose). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was stored in refrigerator on 28-Dec-2022 and was administered on 31-jan-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient received an expired 2nd primary dose), PRODUCT STORAGE ERROR (vial was stored in refrigerator on 28-Dec-2022 and was administered on 31-jan-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (patient received an expired 2nd primary dose) and PRODUCT STORAGE ERROR (vial was stored in refrigerator on 28-Dec-2022 and was administered on 31-jan-2023).    No concomitant medications were reported. The vial was initially stored in the refrigerator was 28-Dec-2022. The vial did not undergo any temperature excursions. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product administration interrupted
Clinical narrative: first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for PRODUCT ADMINISTRATION INTERRUPTED (first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose).    No concomitant product was reported. It was reported that patient received the first Moderna COVID-19 Vaccine dose in May-2021 and never received the second dose. Reporter enquired if there was need to restart the series. No treatment information was reported.
Age: 64.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest discomfort, Chest pain, Discomfort, Influenza, Pain in extremity
Clinical narrative: discomfort; flu symptoms; acute chest pain; discomfort in the chest area/chest is still tight; pain in left leg /leg is still sore; This spontaneous case was reported by a patient and describes the occurrence of DISCOMFORT (discomfort), INFLUENZA (flu symptoms), CHEST PAIN (acute chest pain), CHEST DISCOMFORT (discomfort in the chest area/chest is still tight) and PAIN IN EXTREMITY (pain in left leg /leg is still sore) in a 64-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 041H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: Singles vaccine in 2022 and Singles vaccine in 2022. Past adverse reactions to the above products included No adverse event with Singles vaccine and Singles vaccine. Concurrent medical conditions included Sinusitis, Acid reflux (esophageal) and Seasonal allergy.    On 03-Jan-2023, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Jan-2023, the patient experienced DISCOMFORT (discomfort), INFLUENZA (flu symptoms), CHEST PAIN (acute chest pain), CHEST DISCOMFORT (discomfort in the chest area/chest is still tight) and PAIN IN EXTREMITY (pain in left leg /leg is still sore). The patient was treated with IBUPROFEN (IBUPAR [IBUPROFEN]) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (BABY ASPIRIN) at an unspecified dose and frequency. At the time of the report, DISCOMFORT (discomfort), INFLUENZA (flu symptoms) and CHEST PAIN (acute chest pain) was resolving and CHEST DISCOMFORT (discomfort in the chest area/chest is still tight) and PAIN IN EXTREMITY (pain in left leg /leg is still sore) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not reported.  It was reported that patient received other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient was slowly feeling better and feels like health had been compromised. Patient got two shingles shots 2 months ago.
Sex: U
Vaccine: COVID19-2
Symptoms: Accidental underdose, No adverse event
Clinical narrative: administered 0.25ml of the bivalent booster dose to an adult patient.; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (administered 0.25ml of the bivalent booster dose to an adult patient.) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (administered 0.25ml of the bivalent booster dose to an adult patient.) and NO ADVERSE EVENT (no adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (administered 0.25ml of the bivalent booster dose to an adult patient.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (administered 0.25ml of the bivalent booster dose to an adult patient.).    Concomitant products were not reported.  Treatment medications were not reported.
Age: 17.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Nurse is calling to report that her coworker notified her that she gave a 17-year-old patient a Bivalent Moderna COVID-19 booster dose instead of first primary dose; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (Nurse is calling to report that her coworker notified her that she gave a 17-year-old patient a Bivalent Moderna COVID-19 booster dose instead of first primary dose) and NO ADVERSE EVENT (No adverse event) in a 17-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 019H22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: INFLUENZA VACCINE. Past adverse reactions to the above products included No adverse event with INFLUENZA VACCINE.    On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Nurse is calling to report that her coworker notified her that she gave a 17-year-old patient a Bivalent Moderna COVID-19 booster dose instead of first primary dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Nurse is calling to report that her coworker notified her that she gave a 17-year-old patient a Bivalent Moderna COVID-19 booster dose instead of first primary dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Nurse is calling to report that her coworker notified her that she gave a 17-year-old patient a Bivalent Moderna COVID-19 booster dose instead of first primary dose).    Concomitant product use was not provided by the reporter. Patient received other vaccines  4 weeks prior to COVID-19 vaccine. Treatment information was not provided.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Swelling in the left arm of about 2 cm. Same arm of the injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling in the left arm of about 2 cm. Same arm of the injection) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057M21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE SWELLING (Swelling in the left arm of about 2 cm. Same arm of the injection). At the time of the report, VACCINATION SITE SWELLING (Swelling in the left arm of about 2 cm. Same arm of the injection) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had no allergy or diseases. No concomitant product was reported. The patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. No treatment information was reported.
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Doses were stored in the fridge since 20Dec2022 and vaccines were administered on 24Jan2023; No adverse event; Pediatric patient was administered with Moderna COVID-19 Vaccine Bivalent doses after 30-day Use By Date (34 days); This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Pediatric patient was administered with Moderna COVID-19 Vaccine Bivalent doses after 30-day Use By Date (34 days)), PRODUCT STORAGE ERROR (Doses were stored in the fridge since 20Dec2022 and vaccines were administered on 24Jan2023) and NO ADVERSE EVENT (No adverse event) in an infant patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 24-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .2 milliliter. On 24-Jan-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Pediatric patient was administered with Moderna COVID-19 Vaccine Bivalent doses after 30-day Use By Date (34 days)). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Doses were stored in the fridge since 20Dec2022 and vaccines were administered on 24Jan2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Pediatric patient was administered with Moderna COVID-19 Vaccine Bivalent doses after 30-day Use By Date (34 days)), PRODUCT STORAGE ERROR (Doses were stored in the fridge since 20Dec2022 and vaccines were administered on 24Jan2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Pediatric patient was administered with Moderna COVID-19 Vaccine Bivalent doses after 30-day Use By Date (34 days)) and PRODUCT STORAGE ERROR (Doses were stored in the fridge since 20Dec2022 and vaccines were administered on 24Jan2023).    Concomitant product use was not provided by the reporter. This case has information of 1 pediatric patient out of 2 pediatric patient case. Patient received initial booster dose.  It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-706726 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-706726:Patient 2 of 2
Age: 86.0
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No Adverse Event; Bivalent vaccine was given 2 days beyond BUD; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine was given 2 days beyond BUD) and NO ADVERSE EVENT (No Adverse Event) in an 86-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7168B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Jan-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine was given 2 days beyond BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine was given 2 days beyond BUD) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine was given 2 days beyond BUD).    No concomitant medication were reported. No treatment medication were reported.
Age: 67.0
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Bivalent vaccine was given 2 days beyond BUD.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine was given 2 days beyond BUD.) and NO ADVERSE EVENT (No adverse event) in a 67-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7168B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Jan-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Jan-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine was given 2 days beyond BUD.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine was given 2 days beyond BUD.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Bivalent vaccine was given 2 days beyond BUD.).    No concomitant drug information was provided.  No treatment medication information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered 17-Nov-2022; No adverse event; 4 adults patients received doses after its beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date), PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered 17-Nov-2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 17-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 17-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered 17-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date), PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered 17-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (4 adults patients received doses after its beyond use date) and PRODUCT STORAGE ERROR (Date vials were initially thawed: shipment received in liquid state on Oct 11 2022, vaccine was administered 17-Nov-2022).    Concomitant product use was not provided by the reporter.  Vials did not undergone any temperature excursions.  Treatment information was not provided.
Age: 36.0
Sex: F
Vaccine: ANTH
Symptoms: Mobility decreased, Oedema
Clinical narrative: Unable to move arm for over 7 days, edema and steroids needed to control pain
Age: 0.92
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Viral test positive
Clinical narrative: He tested positive for COVID-19 on 1/23/23. He had a low-grade fever, and congestion. He had Rhinovirus the week before he tested positive for COVID-19. So, I think his chest congestion was due to that. He has a nebulizer, and we gave him a breathing treatment in the mornings, and we also gave him Children's Motrin. No other medications were prescribed. He is back to normal now.
Age: 62.0
Sex: M
Vaccine: HIBV, MNQ
Symptoms: Wrong product administered
Clinical narrative: The patient received MenQuadfi IM when he had just received Menactra IM on 1/19/23 and was supposed to received one of the meningococcal B vaccines today (Trumenba or Bexsero).  Wrong vaccine given
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Heavy menstrual bleeding, Menstruation irregular
Clinical narrative: Irregular menstrual cycle - extremely heavy periods, and now have 2 periods per menstrual cycle (period every two weeks).
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood pressure increased, COVID-19, Nasopharyngitis, SARS-CoV-2 test positive
Clinical narrative: My blood pressure has ALWAYS been 95/65 and is now 135/85.  I have not changed my lifestyle.  I used to get a cold every 10 years and now I've had two and tested positive for COVID twice. I've had 2 vaccines and one booster.  I do believe these vaccines will kill us all.
Age: 0.33
Sex: M
Vaccine: DTAPIPV, HIBV, PNC13, RV1
Symptoms: Wrong product administered
Clinical narrative: Pt. was administered Kinrix instead of Pediarix.
Age: 63.0
Sex: M
Vaccine: PNC15, VARZOS
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Muscle aches, head ache, chills
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Balance disorder, Decreased appetite, Developmental regression, Fall, Gait disturbance
Clinical narrative: Regression of walking, unsteadiness standing and while cruising or stepping (improved 1/31) Tendency for falling backwards Intolerance of being brought down to supine position (resolved on 1/30) Reduced appetite for solids and reduced appetite for milk (improved 2/1) Irregular sleep pattern Fussy
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Irritability, Orthostatic intolerance, Sleep disorder
Clinical narrative: Regression of walking, unsteadiness standing and while cruising or stepping (improved 1/31) Tendency for falling backwards Intolerance of being brought down to supine position (resolved on 1/30) Reduced appetite for solids and reduced appetite for milk (improved 2/1) Irregular sleep pattern Fussy
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Arthritis, Back pain, Condition aggravated, Inflammation
Clinical narrative: Patient reports increased inflammation, back and joint pain. Patient treated with Toradol injection and Tylenol/ ibuprofen from PCP.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was given a Monovalent booster instead of a Bivalent booster. Patient has been informed of the immunization error. Patient reports no adverse reaction to the vaccine she received on 9/16/22.
Age: 1.67
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: There was no adverse event. The wrong vaccine was given by mistake. She should have received the Moderna bivalent booster and instead was given the monovalent vaccine.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebral haematoma, Haemorrhagic stroke, Laboratory test
Clinical narrative: I had a hemorrhagic stroke beginning on 10/20/2022. I also had a hematoma in my brain that was discovered early 2023.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: C-reactive protein increased, Condition aggravated, Polymyalgia rheumatica
Clinical narrative: relapse of PMR with CRP eventually hitting 253 (normal is 0 - 9) This necessitated increasing my prednisone dose to 60mg/day starting October 26, 2022.  As of February 02, 2023 I have tapered to 13mg/day.  My CRP is still elevated at 15.4.  On September 27, 2022 my CRP was 6.5.  (My booster was on September29, 2022) On October 13, 2022  my CRP was 106.9.  On Oct. 18, 2022 my CRP was 190.  On Oct 25, 2022 my CRP was 253
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Headache, Lung assist device therapy
Clinical narrative: 2-3 days after shot developed progressive headache and neck pain.  progressive and had imaging  almost a month later.  Dural venous sinus thrombosis.  treated with anticoagulation.  Despite anticoagulation, 6 weeks later had submassive PE that had an acute and chronic component.  unresponsive to thrombolytics and thrombectomy attempt.  Required.  Still hospitalized
Age: 39.0
Sex: F
Vaccine: COVID19-2
Symptoms: Magnetic resonance imaging head abnormal, Neck pain, Pulmonary embolism, Thrombectomy
Clinical narrative: 2-3 days after shot developed progressive headache and neck pain.  progressive and had imaging  almost a month later.  Dural venous sinus thrombosis.  treated with anticoagulation.  Despite anticoagulation, 6 weeks later had submassive PE that had an acute and chronic component.  unresponsive to thrombolytics and thrombectomy attempt.  Required.  Still hospitalized
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Headache, Influenza like illness, Migraine
Clinical narrative: A week after dose 3, my right elbow and then left elbow I was unable to lift anything. It began with trying to lift my kettle. This gradually progressed and got worse and lasted about 4 months. I began to subside but was intermittent. The pain was like they describe as "tennis elbow". I was in another country when this was happening and was unable get care. I was unable to rest my arm without having pain. I have taken ibuprofen to mask the pain but I have not found the cause for the pain. When I returned home I was unable to see a doctor. The pain has subsided enough now that I may not see one for this. Also, in September 2022, I began to have fever like symptoms and a migraine-like headache. I was in another country when this happened. I had a low-grade fever. I had sore throat, headache, classic flu-like symptoms. I tested positive for COVID-19 with a home test on September 8, 2022. I took the prescription antiviral, cefixime in another country, SUPRAX at home, prescribed in other country. I tested negative on September 18, 2022.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Oropharyngeal pain, Pain in extremity, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: A week after dose 3, my right elbow and then left elbow I was unable to lift anything. It began with trying to lift my kettle. This gradually progressed and got worse and lasted about 4 months. I began to subside but was intermittent. The pain was like they describe as "tennis elbow". I was in another country when this was happening and was unable get care. I was unable to rest my arm without having pain. I have taken ibuprofen to mask the pain but I have not found the cause for the pain. When I returned home I was unable to see a doctor. The pain has subsided enough now that I may not see one for this. Also, in September 2022, I began to have fever like symptoms and a migraine-like headache. I was in another country when this happened. I had a low-grade fever. I had sore throat, headache, classic flu-like symptoms. I tested positive for COVID-19 with a home test on September 8, 2022. I took the prescription antiviral, cefixime in another country, SUPRAX at home, prescribed in other country. I tested negative on September 18, 2022.
Age: 8.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: The pt was given 0.2 of the bivalent vaccine before it was reconstituted with diluent.  Pt is not currently having any s/sx
Age: 59.0
Sex: F
Vaccine: UNK
Symptoms: Headache, Pain in extremity
Clinical narrative: Sore L arm and a slight headache
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Chills, Eye swelling, Malaise, Nausea
Clinical narrative: She started itching and developed nausea and vomiting, chills,fever.   Woke up with eyes swollen and big blister under each eye on cheek bone.  General  malaise
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Pyrexia, Vomiting
Clinical narrative: She started itching and developed nausea and vomiting, chills,fever.   Woke up with eyes swollen and big blister under each eye on cheek bone.  General  malaise
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: We gave Pfizer Covid 19 Bivalent Vaccine twice She had her first one in September and second 2/2023. We were unaware she had the one in September
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia, Pain in extremity, Peripheral swelling
Clinical narrative: swelling in hands , joint pain in knees ankles elbows wrist fingerpain
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Impaired work ability, Laboratory test, Lumbar puncture abnormal, Magnetic resonance imaging head abnormal, Multiple sclerosis
Clinical narrative: 5-7/2021 vertigo type symptoms resulted in 2 walk-in clinic visits and missed 2 days work Was referred to ENT for possible inner ear issues; after many tests and money that was ruled out.  An MRI was finally ordered and completed 6/10/2022-moderate white lesions on brain were noted.  9/16/2022 a lumbar puncture also showed results resembling MS. 11/16/2022 drove 5 hours to be diagnosed with MS and begin treatment.  This has been a very long road with many bumps along the way.  My life has forever changed from taking a vaccine that was safe?  I had always been a healthy individual but that has been taken away.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Neurological symptom, White matter lesion
Clinical narrative: 5-7/2021 vertigo type symptoms resulted in 2 walk-in clinic visits and missed 2 days work Was referred to ENT for possible inner ear issues; after many tests and money that was ruled out.  An MRI was finally ordered and completed 6/10/2022-moderate white lesions on brain were noted.  9/16/2022 a lumbar puncture also showed results resembling MS. 11/16/2022 drove 5 hours to be diagnosed with MS and begin treatment.  This has been a very long road with many bumps along the way.  My life has forever changed from taking a vaccine that was safe?  I had always been a healthy individual but that has been taken away.
Age: 9.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dizziness, Headache, Syncope
Clinical narrative: Patient had syncopal episode and fainted. Was subsequently woozy for the next 15 minutes, experienced dizziness and headache.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Asthenia, Feeling abnormal, Headache, Injection site erythema, Injection site swelling
Clinical narrative: Large swollen red spot at injection site. Arm very painful. Headache within couple hours of injection. Next morning sore muscles, no energy, felt sick to stomach. Felt bad all day. 2nd day after still feel no energy but better. Arm not as sore but still large red swollen area. Never had a reaction like this at injectiin site. Covid vaccine are bad but never large swollen red area
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Myalgia, Nausea, Pain in extremity
Clinical narrative: Large swollen red spot at injection site. Arm very painful. Headache within couple hours of injection. Next morning sore muscles, no energy, felt sick to stomach. Felt bad all day. 2nd day after still feel no energy but better. Arm not as sore but still large red swollen area. Never had a reaction like this at injectiin site. Covid vaccine are bad but never large swollen red area
Age: 66.0
Sex: F
Vaccine: FLUR4, FLUR4
Symptoms: Rash
Clinical narrative: Pt reported that she had a rash after leaving our pharmacy, but she did stay at the pharmacy for 30 minutes to be monitored because she mentioned some hx of rash with injections.  Pt took benadryl and rash resolved
Age: 66.0
Sex: F
Vaccine: FLUR4, FLUR4
Symptoms: Erythema, Pruritus, Swelling
Clinical narrative: Pt reported that she had a rash after leaving our pharmacy, but she did stay at the pharmacy for 30 minutes to be monitored because she mentioned some hx of rash with injections.  Pt took benadryl and rash resolved
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin abnormal, Blood test, Burning sensation, Fatigue, Lichen sclerosus
Clinical narrative: Began in January 2022 with just pain under both arms. The pain was mild then became more severe. Noticed a strange rash under both arms. It started about quarter size and slowly began to spread larger and left a strange white spot in the middle as it spread the white patch grew with blister like rash at the edges. There was no itching, just pain and burning. I saw it growing and became alarmed as the pain and the white spot grew under both arms till they were hand size. I went to the doctor finally after trying everything myself to treat it! In January 2023  the dermatologist did not know what it was he took a sample biopsy. I received two different possible diagnoses. I realize these are both related to autoimmune diseases. Lichen Sclerosis et Atrophicus and Morphea. The lab is sending slices of the biopsy to other labs to confirm. I am also going to a Rheumatologist for more blood work. I had two initial CoVid shots Jan 2021 and February 2021 both Pfizer. Then the booster was Sept 2021. After the booster I became very very tired.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Morphoea, Pain in extremity, Rash, Rash vesicular, Skin discolouration
Clinical narrative: Began in January 2022 with just pain under both arms. The pain was mild then became more severe. Noticed a strange rash under both arms. It started about quarter size and slowly began to spread larger and left a strange white spot in the middle as it spread the white patch grew with blister like rash at the edges. There was no itching, just pain and burning. I saw it growing and became alarmed as the pain and the white spot grew under both arms till they were hand size. I went to the doctor finally after trying everything myself to treat it! In January 2023  the dermatologist did not know what it was he took a sample biopsy. I received two different possible diagnoses. I realize these are both related to autoimmune diseases. Lichen Sclerosis et Atrophicus and Morphea. The lab is sending slices of the biopsy to other labs to confirm. I am also going to a Rheumatologist for more blood work. I had two initial CoVid shots Jan 2021 and February 2021 both Pfizer. Then the booster was Sept 2021. After the booster I became very very tired.
Age: 55.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Blood test, Computerised tomogram, Fatigue, Haematuria, Myalgia
Clinical narrative: Gross Hematuria that lasted 2 months.  Sudden onset of muscle passin and fatigue on 3rd day after vaccination.  No treatment. Told to drink a lot of water. When I said that the vaccine caused this condition it was ignored at the medical facilities that I went to for this issue.  It resolved itself after a full 2 months.
Age: 55.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Urine analysis
Clinical narrative: Gross Hematuria that lasted 2 months.  Sudden onset of muscle passin and fatigue on 3rd day after vaccination.  No treatment. Told to drink a lot of water. When I said that the vaccine caused this condition it was ignored at the medical facilities that I went to for this issue.  It resolved itself after a full 2 months.
Age: 55.0
Sex: F
Vaccine: COVID19-2, COVID19
Symptoms: Blood urine, Haematuria, Muscular weakness
Clinical narrative: Gross Hematuria that lasted 2 months.  Sudden onset of muscle passin and fatigue on 3rd day after vaccination.  No treatment. Told to drink a lot of water. When I said that the vaccine caused this condition it was ignored at the medical facilities that I went to for this issue.  It resolved itself after a full 2 months.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT RECEIVED PFIZER MONOVALENT VACCINE INSTEAD OF PFIZER BIVALENT VACCINE BOOSTER
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT RECEIVED PFIZER MONOVALENT VACCINE INSTEAD OF PFIZER BIVALENT VACCINE BOOSTER
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT RECEIVED PFIZER MONOVALENT VACCINE INSTEAD OF PFIZER BIVALENT VACCINE BOOSTER
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT RECEIVED PFIZER MONOVALENT VACCINE INSTEAD OF PFIZER BIVALENT VACCINE BOOSTER
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT RECEIVED PFIZER MONOVALENT VACCINE INSTEAD OF PFIZER BIVALENT VACCINE BOOSTER
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT RECEIVED PFIZER MONOVALENT VACCINE INSTEAD OF PFIZER BIVALENT VACCINE BOOSTER
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT RECEIVED PFIZER MONOVALENT VACCINE INSTEAD OF PFIZER BIVALENT VACCINE BOOSTER
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT RECEIVED PFIZER MONOVALENT VACCINE INSTEAD OF PFIZER BIVALENT VACCINE BOOSTER
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Decreased appetite, Injection site erythema, Injection site swelling, Injection site warmth, Joint swelling
Clinical narrative: Very swollen at injection site, red and hot to touch. Running a fever of 102. Lethargic and no appetite. Leg hurts to walk on and knee is swelling as well.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Lethargy, Pain in extremity, Pyrexia
Clinical narrative: Very swollen at injection site, red and hot to touch. Running a fever of 102. Lethargic and no appetite. Leg hurts to walk on and knee is swelling as well.
Age: 24.0
Sex: M
Vaccine: FLUC4
Symptoms: Dyspnoea, Pruritus, Rash, Urticaria
Clinical narrative: Immediate rash and intense itching over the entire body the next morning. Difficulty breathing starting 5 days after the vaccination. Raised hives over entire body. Symptoms disappear after taking a combination of allegra, famotidine, and xyzal as prescribed by allergist. Symptoms reappear as soon as antihistamines are stopped, symptoms have lasted for nearly a month.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Arthralgia, Erythema, Fatigue, Headache, Injection site erythema
Clinical narrative: NDC # 0006-4837-03 local reaction of erythema, edema, warmth expanded well beyond the immediate injection site from the top of the lt. shoulder down to the elbow area, into my Lt. axilla & Lt pectoral area. It was extremely swollen and painful. I was concerned it could be cellulitis. I also had fatigue, headache, knee joint pain. The reaction resolved by date.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Injection site oedema, Injection site warmth, Oedema peripheral, Peripheral swelling, Skin warm
Clinical narrative: NDC # 0006-4837-03 local reaction of erythema, edema, warmth expanded well beyond the immediate injection site from the top of the lt. shoulder down to the elbow area, into my Lt. axilla & Lt pectoral area. It was extremely swollen and painful. I was concerned it could be cellulitis. I also had fatigue, headache, knee joint pain. The reaction resolved by date.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased
Clinical narrative: 5pm-7:30pm-heart rate 133-143 (sitting & laying) normal "70's"- drank "sleepy time tea" w/valerin in it to reduce 7:30pm after tea 130-135 heart rate 8pm - took benedryl (1) & herbal "sleeprelief" with melatonin & valerin root in it to reduce. 11pm - heart rate-99 - went to bed 8AM - woke up 62-heart rate-normal
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient received vaccine 4 month before 18th Birthday No adverse event reported F/u by Provider 3/23/21
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Back pain, Chills, Feeling abnormal, Headache, Injection site pain
Clinical narrative: Headache, back pain, neck pain, paint at injection site. "Feeling Down" feels sick, body aches, chills.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Malaise, Neck pain, Pain
Clinical narrative: Headache, back pain, neck pain, paint at injection site. "Feeling Down" feels sick, body aches, chills.
Age: 1.75
Sex: M
Vaccine: DTAPIPVHIB, HEPA, MMR, VARCEL
Symptoms: Expired product administered
Clinical narrative: Patient was given expired Pentacel. Expiration date was in the following form: 28Jan23, so the MA thought this was 1-23-28 because the other vaccines had exp dates in this form: YYYY-MO-DATE. Sanofi was notified today and the expiration date was confirmed to be 1-28-23. Adverse event was filed with Sanofi as well. Sanofi is going to send this to their Quality and Safety division to see about having the dates written in a different form so as to not be confusing.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product use issue
Clinical narrative: Adult Dose 0.5 Moderna given 4 days past the Do not use beyond Date of 1-27-2023. Given Jan 31, 2023 No adverse reaction
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Platelet count decreased, Platelet transfusion, Skin discolouration, Tongue disorder
Clinical narrative: Patient woke up with spots on tongue, later same day spots red & purple on legs. Went to Urgent Care told to go to ER immediately. Admitted to Hospital, Platelet count drop significantly. Receive 2 Units of Platelets placed on steroids.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Dehydration, Feeling hot, Hyperhidrosis, Mobility decreased
Clinical narrative: Weakness, unable to move, Nauseous, unresponsive, sweaty, hot, no fever, felt dehydrated.  Similar to an Addisonian Crisis.  Lasted about an hour.  Took an extra Cortef, drank water and diet coke, rested.  Then ate bowl of soup.  Same thing happened after 1st vaccine, but 7 days later.  Didn't realize it was from the vaccine.